ClinConnect ClinConnect Logo
Search / Trial NCT06173609

Long LIMA Patch on Left Anterior Descending Coronary Artery in CABG

Launched by ASSIUT UNIVERSITY · Dec 8, 2023

Trial Information

Current as of July 25, 2025

Not yet recruiting

Keywords

Cabg Lima

ClinConnect Summary

This clinical trial is studying a new approach to help patients with a specific type of heart disease called coronary artery disease (CAD). The focus is on using a special technique called the LIMA patch to repair a part of the heart's artery known as the left anterior descending coronary artery (LAD). The goal is to see how well this method works for patients who have widespread problems in the LAD, both in the short term and in the months following the surgery.

To participate in this trial, patients should be between the ages of 30 and 90, and they must have ischemic heart disease, which is a condition that can lead to chest pain and heart problems. However, if a patient has already had open heart surgery in the past, they won't be eligible for this study. This trial is currently not recruiting participants, but if you meet the criteria and are interested, it's a chance to contribute to new treatments for heart disease. Participants will receive close monitoring and care throughout the study to ensure their safety and well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Any patient male,( or female) and his(or her) age from 30-90 years have Ischemic Heart Disease for CABG with diffusely diseased LAD.
  • Exclusion Criteria:
  • Any patient performed open heart surgery before

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Trial Officials

Sameh Abdelrahman, professor

Study Chair

Professor of Cardiothoracic surgery

Ahmed Mohamed Taha, professor

Principal Investigator

Professor of Cardiothoracic surgery

Mohammed Hasan Osman, professor

Study Director

Professor of General surgery Maxillofacial surgery

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported